Clinical Trial Update: Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy

View source ↗

Summary

This NIH-sponsored clinical trial evaluating an isoproterenol challenge for detecting arrhythmogenic right ventricular cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Cardiomyopathy

Drugs mentioned

• Isoproterenol (isoproterenol)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Arrhythmic Right Ventricular Cardiomyopathy | Status: COMPLETED